Language

News topic

Active ingredient TENOFOVIR DISOPROXIL

Current shortage notices for the active ingredient TENOFOVIR DISOPROXIL, structured by product, country and reporting period.

6 notices

← All shortages

What the TENOFOVIR DISOPROXIL notices indicate for the supply chain

The 6 consolidated notices from Austria, Belgium, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Austria

Tenofovir Sandoz 245 mg – Filmtabletten

Active ingredient: TENOFOVIR DISOPROXIL

View notice details →
Belgium

Tenofovir Disoproxil Viatris 245 mg film-coat. tabl. 30

Active ingredient: Tenofovir Disoproxil

View notice details →
Belgium

Emtricitabine/Tenofovir Disoproxil Krka 200 mg - 245 mg filmomh. tabl. 90 (3 x 30)

Active ingredient: Emtricitabine; Tenofovir Disoproxil

View notice details →
Belgium

Emtricitabine/Tenofovir Disoproxil Mylan 200 mg - 245 mg filmomh. tabl. 30 (30 x 1) UD

Active ingredient: Emtricitabine; Tenofovir Disoproxil

View notice details →
Czechia

TENOFOVIR DISOPROXIL ACCORDPHARMA 245MG TBL FLM 30X1

Active ingredient: TENOFOVIR-DISOPROXIL

View notice details →
Austria

Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg Filmtabletten

Active ingredient: EMTRICITABIN; TENOFOVIR DISOPROXIL

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.